Astera Labs (NASDAQ:ALAB) Trading Down 7.5% – What’s Next?

07 Jan 2026, 21:58 by Doug Wharley · The Cerbat Gem

Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report)’s stock price fell 7.5% on Monday . The company traded as low as $166.13 and last traded at $166.15. 2,679,115 shares were traded during mid-day trading, a decline of 30% from the average session volume of 3,846,124 shares. The stock had previously closed at $179.56.

Analyst Ratings Changes

Several analysts have recently commented on ALAB shares. JPMorgan Chase & Co. raised their target price on shares of Astera Labs from $180.00 to $215.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 5th. Northland Capmk raised shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a report on Monday, November 17th. TD Cowen lowered their price objective on Astera Labs from $225.00 to $170.00 and set a “hold” rating on the stock in a report on Wednesday, November 5th. Stifel Nicolaus boosted their target price on Astera Labs from $185.00 to $200.00 and gave the stock a “buy” rating in a research report on Wednesday, November 5th. Finally, Zacks Research cut Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, October 6th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $188.17.

View Our Latest Research Report on ALAB

Astera Labs Stock Performance

The stock’s 50-day moving average price is $160.53 and its 200-day moving average price is $162.31. The company has a market capitalization of $28.00 billion, a price-to-earnings ratio of 149.34, a P/E/G ratio of 2.20 and a beta of 1.50.

Astera Labs (NASDAQ:ALAB – Get Free Report) last released its quarterly earnings data on Tuesday, November 4th. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.39 by $0.10. The firm had revenue of $230.58 million during the quarter, compared to the consensus estimate of $206.42 million. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.Astera Labs’s quarterly revenue was up 103.9% on a year-over-year basis. During the same period last year, the business posted $0.23 EPS. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. Analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Insider Activity at Astera Labs

In related news, General Counsel Philip Mazzara sold 4,620 shares of the company’s stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $668,467.80. Following the sale, the general counsel owned 147,040 shares of the company’s stock, valued at approximately $21,275,217.60. This represents a 3.05% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Jitendra Mohan sold 90,459 shares of the firm’s stock in a transaction on Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $13,088,512.71. Following the transaction, the chief executive officer directly owned 2,080,418 shares of the company’s stock, valued at $301,015,680.42. The trade was a 4.17% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 576,936 shares of company stock valued at $87,409,540 in the last quarter. 12.50% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Astera Labs

A number of institutional investors have recently bought and sold shares of ALAB. Vident Advisory LLC purchased a new stake in shares of Astera Labs during the 1st quarter worth about $207,000. Royal Bank of Canada raised its holdings in Astera Labs by 167.3% in the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock valued at $9,097,000 after buying an additional 95,409 shares during the period. AQR Capital Management LLC lifted its position in Astera Labs by 213.4% during the first quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock valued at $680,000 after buying an additional 7,756 shares in the last quarter. Petrus Trust Company LTA purchased a new stake in Astera Labs during the first quarter worth approximately $219,000. Finally, Jones Financial Companies Lllp grew its stake in Astera Labs by 15,180.1% during the first quarter. Jones Financial Companies Lllp now owns 20,781 shares of the company’s stock worth $1,240,000 after buying an additional 20,645 shares during the period. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Astera Labs Company Profile

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.